Valneva SE (VALN) Short-term Investments (2020 - 2025)

Valneva SE (VALN) posted Short-term Investments of $1.5 million for Q2 2025, up 10.48% sequentially from $1.3 million in Q4 2024.

Analysis

Valneva SE (VALN) Short-term Investments (2020 - 2025) Analysis & Trends

Valneva SE has reported Short-term Investments for 2 years, with the latest figure at $1.5 million in Q2 2025.

Quarterly Short-term Investments changed N/A year-over-year to $1.5 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $1.5 million (changed N/A YoY) and the FY2024 annual result came in at $1.4 million, changed N/A from the prior year.
Short-term Investments rose to $1.5 million in Q2 2025 per VALN's latest filing, from $1.3 million in the prior quarter.
Over five years, Short-term Investments peaked at $1.5 million in Q2 2025 and troughed at $1.3 million in Q4 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.43 Bn	130.58 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn
3	Argenx Se	63.34 Bn	58.15 Bn	1.37 Bn
4	Moderna	57.98 Bn	52.85 Bn	52.00 Mn
5	Revolution Medicines	43.98 Bn	43.98 Bn	-
6	BeOne Medicines	39.92 Bn	34.82 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.42 Bn	32.11 Bn	992.69 Mn
8	Royalty Pharma	28.42 Bn	27.58 Bn	-
9	Insmed	27.36 Bn	26.20 Bn	358.27 Mn
10	Valneva SE	580.64 Mn	439.38 Mn	1.86 Mn

Historic Data

Download Data